6782 — Visco Vision Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Visco Vision, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	116	404	713	296	740
Depreciation
Amortisation
Non-Cash Items	84.7	-12.3	33.5	30.3	0.159
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-97.5	-26.1	-97.2	-378	-66.7
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	281	608	985	353	1,116
Capital Expenditures	-294	-903	-932	-450	-509
Purchase of Fixed Assets
Other Investing Cash Flow Items	-293	154	-31.1	-489	-3.26
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-587	-748	-963	-939	-512
Financing Cash Flow Items	626	710	1,020	—	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	354	288	1,409	-667	-418
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	34.8	114	1,450	-1,281	237